These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 17274671)
1. Modifying the sugar moieties of daunorubicin overcomes P-gp-mediated multidrug resistance. Battisti RF; Zhong Y; Fang L; Gibbs S; Shen J; Nadas J; Zhang G; Sun D Mol Pharm; 2007; 4(1):140-53. PubMed ID: 17274671 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059 [TBL] [Abstract][Full Text] [Related]
3. Role of Aromatic and Negatively Charged Residues of DrrB in Multisubstrate Specificity Conferred by the DrrAB System of Streptomyces peucetius. Brown K; Li W; Kaur P Biochemistry; 2017 Apr; 56(13):1921-1931. PubMed ID: 28272881 [TBL] [Abstract][Full Text] [Related]
4. Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia. Zhang G; Fang L; Zhu L; Zhong Y; Wang PG; Sun D J Med Chem; 2006 Mar; 49(5):1792-9. PubMed ID: 16509594 [TBL] [Abstract][Full Text] [Related]
5. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells]. Yi J; Chen J; Sun J; Wei HL Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1741-4. PubMed ID: 19862976 [TBL] [Abstract][Full Text] [Related]
7. Functional role of the linker region in purified human P-glycoprotein. Sato T; Kodan A; Kimura Y; Ueda K; Nakatsu T; Kato H FEBS J; 2009 Jul; 276(13):3504-16. PubMed ID: 19490125 [TBL] [Abstract][Full Text] [Related]
8. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885 [TBL] [Abstract][Full Text] [Related]
9. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity. Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726 [TBL] [Abstract][Full Text] [Related]
10. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives. Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006 [TBL] [Abstract][Full Text] [Related]
12. The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Sun S; Chen Z; Li L; Sun D; Tian Y; Pan H; Bi H; Huang M; Zeng S; Jiang H Xenobiotica; 2012 Dec; 42(12):1197-205. PubMed ID: 22900779 [TBL] [Abstract][Full Text] [Related]
13. The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin. Loetchutinat C; Heywang C; Priebe W; Garnier-Suillerot A Biochem Pharmacol; 2001 Sep; 62(5):561-7. PubMed ID: 11585053 [TBL] [Abstract][Full Text] [Related]
14. Jatrophane diterpenoids from Euphorbia sororia as potent modulators against P-glycoprotein-based multidrug resistance. Hu R; Gao J; Rozimamat R; Aisa HA Eur J Med Chem; 2018 Feb; 146():157-170. PubMed ID: 29407947 [TBL] [Abstract][Full Text] [Related]
15. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors. Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of a 3'-azido analogue of Doxorubicin against drug-resistant cancer cells. Yu S; Zhang G; Zhang W; Luo H; Qiu L; Liu Q; Sun D; Wang PG; Wang F Int J Mol Sci; 2012; 13(3):3671-3684. PubMed ID: 22489175 [TBL] [Abstract][Full Text] [Related]
17. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells. Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745 [TBL] [Abstract][Full Text] [Related]
18. Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. Nguyen VT; Darbour N; Bayet C; Doreau A; Raad I; Phung BH; Dumontet C; Di Pietro A; Dijoux-Franca MG; Guilet D Fitoterapia; 2009 Jan; 80(1):39-42. PubMed ID: 18940238 [TBL] [Abstract][Full Text] [Related]